BFA Logo Transparent (002).png
DXCM INVESTOR UPDATE: Suffer Losses on Your DexCom, Inc. Investment? Contact BFA Law by October 21 about Pending Class Action Lawsuit (Nasdaq:DXCM)
19 sept. 2024 07h11 HE | Bleichmar Fonti & Auld
DexCom, Inc. investors that lost money on their investment are encouraged to contact BFA Law before October 21, 2024 legal deadline.
BFA Logo Transparent (002).png
DXCM FRAUD ALERT: A Securities Fraud Lawsuit has been Filed against DexCom, Inc. – Investors are Notified to Contact BFA Law before October 21 Deadline (Nasdaq:DXCM)
17 sept. 2024 06h11 HE | Bleichmar Fonti & Auld
DexCom, Inc. investors that lost money on their investment are encouraged to contact BFA Law before October 21, 2024 legal deadline.
BFA Logo Transparent (002).png
DXCM STOCK ALERT: DexCom, Inc. Investors are Notified of Imminent October 21 Deadline in Class Action; Inform BFA Law if you Incurred Losses (Nasdaq:DXCM)
15 sept. 2024 06h36 HE | Bleichmar Fonti & Auld
DexCom, Inc. investors that lost money on their investment are encouraged to contact BFA Law before October 21, 2024 legal deadline.
SABPrimaryLogoColorRGB900px72ppi.png
SAB BIO CEO to Participate in Fireside Chat at 2024 Cantor Global Healthcare Conference
13 sept. 2024 07h00 HE | SAB Biotherapeutics, Inc.
MIAMI, Sept. 13, 2024 (GLOBE NEWSWIRE) -- SAB BIO (Nasdaq: SABS) (the “Company” or “SAB”), a clinical-stage biopharmaceutical company with a novel immunotherapy platform developing a human...
BFA Logo Transparent (002).png
DXCM INVESTOR DEADLINE: DexCom, Inc. Investors that Lost Money are Reminded to Contact BFA Law by October 21 Court Deadline in Class Action Lawsuit (Nasdaq:DXCM)
13 sept. 2024 06h37 HE | Bleichmar Fonti & Auld
DexCom, Inc. investors that lost money on their investment are encouraged to contact BFA Law before October 21, 2024 legal deadline.
BFA Logo Transparent (002).png
DXCM LAWSUIT NEWS: A Class Action Lawsuit has been Filed Against DexCom, Inc. for Securities Fraud; Contact BFA Law before October 21 Legal Deadline (Nasdaq:DXCM)
11 sept. 2024 06h31 HE | Bleichmar Fonti & Auld
DexCom, Inc. investors that lost money on their investment are encouraged to contact BFA Law before October 21, 2024 legal deadline.
BFA Logo Transparent (002).png
DXCM FRAUD ALERT: DexCom, Inc. has been Sued for Securities Fraud – Contact BFA Law by October 21 if You Suffered Losses on Your Investment (Nasdaq:DXCM)
09 sept. 2024 15h33 HE | Bleichmar Fonti & Auld
DexCom, Inc. investors that lost money on their investment are encouraged to contact BFA Law before October 21, 2024 legal deadline.
Balamurugan N. Appakalai, Ph.D.-1
World-renowned diabetes researcher joins Wendy Novak Diabetes Institute
09 sept. 2024 10h30 HE | Norton Healthcare
LOUISVILLE, Ky., Sept. 09, 2024 (GLOBE NEWSWIRE) -- An internationally known researcher is joining Wendy Novak Diabetes Institute, a part of Norton Healthcare and Norton Children’s, with the goal of...
BFA Logo Transparent (002).png
DXCM DEADLINE REMINDER: DexCom, Inc. Investors who Lost Money are Reminded to Contact BFA Law before Upcoming Securities Litigation Deadline (Nasdaq:DXCM)
07 sept. 2024 07h16 HE | Bleichmar Fonti & Auld
DexCom, Inc. investors that lost money on their investment are encouraged to contact BFA Law before October 21, 2024 legal deadline.
22157.jpg
Digital Marketing Trends in Type 2 Diabetes
03 sept. 2024 10h45 HE | Research and Markets
Dublin, Sept. 03, 2024 (GLOBE NEWSWIRE) -- The "Digital Marketing Trends in Type 2 Diabetes - April 2024" report has been added to ResearchAndMarkets.com's offering. This report provides an...